Chemistry:Histamine glutarimide
From HandWiki
Short description: Chemical compound
 | |
| Clinical data | |
|---|---|
| Other names | XC-8 |
| Legal status | |
| Legal status |
|
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| DrugBank | |
| ChemSpider | |
| UNII | |
| Chemical and physical data | |
| Formula | C10H13N3O2 |
| Molar mass | 207.233 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Histamine glutarimide is an investigational new drug that is being evaluated for the treatment of cough in acute respiratory infection.[1][2] It is a glutaminyl cyclase inhibitor.[3]
References
- ↑ "Histamine glutarimide - EURRUS Biotech". AdisInsight. Springer Nature Switzerland AG. https://adisinsight.springer.com/drugs/800047677.
- ↑ Clinical trial number NCT05273619 for "Efficacy and Safety of XC8, Film-coated Tablets, 40 mg in Patients With Dry Non-productive Cough Against Acute Respiratory Viral Infection" at ClinicalTrials.gov
- ↑ "New Anti-Chemokine Oral Drug XC8 in the Treatment of Asthma Patients with Poor Response to Corticosteroids: Results of a Phase 2A Randomized Controlled Clinical Trial". Pulmonary Therapy 6 (2): 351–369. December 2020. doi:10.1007/s41030-020-00134-5. PMID 33095411.
 |  |
